Related News
AIDS gel with Gilead drug protects women in study
Source: Agencies |
July 20, 2010, Tuesday
|
Online Edition
Online Edition
AA GEL made using Gilead Sciences Inc's HIV drug tenofovir reduced HIV infections in women by 39 percent over two and a half years -- the first time such an approach has protected against the virus, South African researchers reported today.
In addition, the gel reduced the risk a woman would get genital herpes by 51 percent, a surprise finding that adds further benefits, Dr. Salim Abdool Karim at the University of KwaZulu-Natal in Durban, South Africa said in results to be released at the International AIDS Conference in Vienna.
In addition, the gel reduced the risk a woman would get genital herpes by 51 percent, a surprise finding that adds further benefits, Dr. Salim Abdool Karim at the University of KwaZulu-Natal in Durban, South Africa said in results to be released at the International AIDS Conference in Vienna.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
